Is there any relationship between expressions of minor blood group antigens with HTLV-I infection?

The frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2–3% in the general population and 0.7% in blood donors in northeast Iran. It is very important that we recognize the contributing factors in the pathogenesis of this virus. There are many reports that show that susceptibility to some infecti...

Full description

Saved in:
Bibliographic Details
Published inTransfusion and apheresis science Vol. 47; no. 2; pp. 151 - 154
Main Authors Sadeghian, Mohammad Hadi, Keramati, Mohammad Reza, Ayatollahi, Hossein, Feizabadi, Atefeh Shirinzadeh, Tehranaian, Farahnaz, Shakibyee, Hossein
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.10.2012
Subjects
Online AccessGet full text
ISSN1473-0502
1878-1683
DOI10.1016/j.transci.2012.06.012

Cover

Abstract The frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2–3% in the general population and 0.7% in blood donors in northeast Iran. It is very important that we recognize the contributing factors in the pathogenesis of this virus. There are many reports that show that susceptibility to some infections is closely linked to the expression of certain blood group antigens. This study was performed to evaluate any association between minor blood group antigens and HTLV-I infection in northeast Iran. In this case and control study major and minor blood group antigens were typed by commercial antibodies in 100 HTLV-I infected individuals and 332 healthy blood donors in Mashhad, Iran, from 2009–2010. Blood group antigens were determined by tube method less than 24h after blood collection. Finally, the results of HTLV-I positive subjects and control groups were compared by using SPSS software. The prevalence of Lea, Leb, P1, Fya, Fyb, M, N, Jka, Jkb, K and k antigens in case group were 39.0%, 56.0%, 72.0%, 67.0%, 52.0%, 90.0%, 57.0%, 79.0%, 71.0%, 10.0%, 96.0%, respectively and the frequency of these blood group antigens in control group were 38.8%, 55.8%, 66.2%, 72.0%, 58.7%, 87.0%, 56.7%, 79.8%, 63.0%, 10.6%, 97.0%, respectively. We did not find any significant differences between the case and control group for frequency of minor blood group antigens. Our study showed minor blood group antigens are not associated with an increased risk of HTLT-1 infection in northeast Iran.
AbstractList The frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2-3% in the general population and 0.7% in blood donors in northeast Iran. It is very important that we recognize the contributing factors in the pathogenesis of this virus. There are many reports that show that susceptibility to some infections is closely linked to the expression of certain blood group antigens. This study was performed to evaluate any association between minor blood group antigens and HTLV-I infection in northeast Iran.BACKGROUNDThe frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2-3% in the general population and 0.7% in blood donors in northeast Iran. It is very important that we recognize the contributing factors in the pathogenesis of this virus. There are many reports that show that susceptibility to some infections is closely linked to the expression of certain blood group antigens. This study was performed to evaluate any association between minor blood group antigens and HTLV-I infection in northeast Iran.In this case and control study major and minor blood group antigens were typed by commercial antibodies in 100 HTLV-I infected individuals and 332 healthy blood donors in Mashhad, Iran, from 2009-2010. Blood group antigens were determined by tube method less than 24h after blood collection. Finally, the results of HTLV-I positive subjects and control groups were compared by using SPSS software.METHODSIn this case and control study major and minor blood group antigens were typed by commercial antibodies in 100 HTLV-I infected individuals and 332 healthy blood donors in Mashhad, Iran, from 2009-2010. Blood group antigens were determined by tube method less than 24h after blood collection. Finally, the results of HTLV-I positive subjects and control groups were compared by using SPSS software.The prevalence of Le(a), Le(b), P1, Fy(a), Fy(b), M, N, Jka, Jkb, K and k antigens in case group were 39.0%, 56.0%, 72.0%, 67.0%, 52.0%, 90.0%, 57.0%, 79.0%, 71.0%, 10.0%, 96.0%, respectively and the frequency of these blood group antigens in control group were 38.8%, 55.8%, 66.2%, 72.0%, 58.7%, 87.0%, 56.7%, 79.8%, 63.0%, 10.6%, 97.0%, respectively. We did not find any significant differences between the case and control group for frequency of minor blood group antigens.RESULTSThe prevalence of Le(a), Le(b), P1, Fy(a), Fy(b), M, N, Jka, Jkb, K and k antigens in case group were 39.0%, 56.0%, 72.0%, 67.0%, 52.0%, 90.0%, 57.0%, 79.0%, 71.0%, 10.0%, 96.0%, respectively and the frequency of these blood group antigens in control group were 38.8%, 55.8%, 66.2%, 72.0%, 58.7%, 87.0%, 56.7%, 79.8%, 63.0%, 10.6%, 97.0%, respectively. We did not find any significant differences between the case and control group for frequency of minor blood group antigens.Our study showed minor blood group antigens are not associated with an increased risk of HTLT-1 infection in northeast Iran.CONCLUSIONOur study showed minor blood group antigens are not associated with an increased risk of HTLT-1 infection in northeast Iran.
The frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2-3% in the general population and 0.7% in blood donors in northeast Iran. It is very important that we recognize the contributing factors in the pathogenesis of this virus. There are many reports that show that susceptibility to some infections is closely linked to the expression of certain blood group antigens. This study was performed to evaluate any association between minor blood group antigens and HTLV-I infection in northeast Iran. In this case and control study major and minor blood group antigens were typed by commercial antibodies in 100 HTLV-I infected individuals and 332 healthy blood donors in Mashhad, Iran, from 2009-2010. Blood group antigens were determined by tube method less than 24h after blood collection. Finally, the results of HTLV-I positive subjects and control groups were compared by using SPSS software. The prevalence of Le(a), Le(b), P1, Fy(a), Fy(b), M, N, Jka, Jkb, K and k antigens in case group were 39.0%, 56.0%, 72.0%, 67.0%, 52.0%, 90.0%, 57.0%, 79.0%, 71.0%, 10.0%, 96.0%, respectively and the frequency of these blood group antigens in control group were 38.8%, 55.8%, 66.2%, 72.0%, 58.7%, 87.0%, 56.7%, 79.8%, 63.0%, 10.6%, 97.0%, respectively. We did not find any significant differences between the case and control group for frequency of minor blood group antigens. Our study showed minor blood group antigens are not associated with an increased risk of HTLT-1 infection in northeast Iran.
The frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2–3% in the general population and 0.7% in blood donors in northeast Iran. It is very important that we recognize the contributing factors in the pathogenesis of this virus. There are many reports that show that susceptibility to some infections is closely linked to the expression of certain blood group antigens. This study was performed to evaluate any association between minor blood group antigens and HTLV-I infection in northeast Iran. In this case and control study major and minor blood group antigens were typed by commercial antibodies in 100 HTLV-I infected individuals and 332 healthy blood donors in Mashhad, Iran, from 2009–2010. Blood group antigens were determined by tube method less than 24h after blood collection. Finally, the results of HTLV-I positive subjects and control groups were compared by using SPSS software. The prevalence of Lea, Leb, P1, Fya, Fyb, M, N, Jka, Jkb, K and k antigens in case group were 39.0%, 56.0%, 72.0%, 67.0%, 52.0%, 90.0%, 57.0%, 79.0%, 71.0%, 10.0%, 96.0%, respectively and the frequency of these blood group antigens in control group were 38.8%, 55.8%, 66.2%, 72.0%, 58.7%, 87.0%, 56.7%, 79.8%, 63.0%, 10.6%, 97.0%, respectively. We did not find any significant differences between the case and control group for frequency of minor blood group antigens. Our study showed minor blood group antigens are not associated with an increased risk of HTLT-1 infection in northeast Iran.
Background: The frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2-3% in the general population and 0.7% in blood donors in northeast Iran. It is very important that we recognize the contributing factors in the pathogenesis of this virus. There are many reports that show that susceptibility to some infections is closely linked to the expression of certain blood group antigens. This study was performed to evaluate any association between minor blood group antigens and HTLV-I infection in northeast Iran. Methods: In this case and control study major and minor blood group antigens were typed by commercial antibodies in 100 HTLV-I infected individuals and 332 healthy blood donors in Mashhad, Iran, from 2009-2010. Blood group antigens were determined by tube method less than 24 h after blood collection. Finally, the results of HTLV-I positive subjects and control groups were compared by using SPSS software. Results: The prevalence of Lea, Leb, P1, Fya, Fyb, M, N, Jka, Jkb, K and k antigens in case group were 39.0%, 56.0%, 72.0%, 67.0%, 52.0%, 90.0%, 57.0%, 79.0%, 71.0%, 10.0%, 96.0%, respectively and the frequency of these blood group antigens in control group were 38.8%, 55.8%, 66.2%, 72.0%, 58.7%, 87.0%, 56.7%, 79.8%, 63.0%, 10.6%, 97.0%, respectively. We did not find any significant differences between the case and control group for frequency of minor blood group antigens. Conclusions: Our study showed minor blood group antigens are not associated with an increased risk of HTLT-1 infection in northeast Iran.
AbstractBackgroundThe frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2–3% in the general population and 0.7% in blood donors in northeast Iran. It is very important that we recognize the contributing factors in the pathogenesis of this virus. There are many reports that show that susceptibility to some infections is closely linked to the expression of certain blood group antigens. This study was performed to evaluate any association between minor blood group antigens and HTLV-I infection in northeast Iran. MethodsIn this case and control study major and minor blood group antigens were typed by commercial antibodies in 100 HTLV-I infected individuals and 332 healthy blood donors in Mashhad, Iran, from 2009–2010. Blood group antigens were determined by tube method less than 24 h after blood collection. Finally, the results of HTLV-I positive subjects and control groups were compared by using SPSS software. ResultsThe prevalence of Le a, Le b, P1, Fy a, Fy b, M, N, Jka, Jkb, K and k antigens in case group were 39.0%, 56.0%, 72.0%, 67.0%, 52.0%, 90.0%, 57.0%, 79.0%, 71.0%, 10.0%, 96.0%, respectively and the frequency of these blood group antigens in control group were 38.8%, 55.8%, 66.2%, 72.0%, 58.7%, 87.0%, 56.7%, 79.8%, 63.0%, 10.6%, 97.0%, respectively. We did not find any significant differences between the case and control group for frequency of minor blood group antigens. ConclusionOur study showed minor blood group antigens are not associated with an increased risk of HTLT-1 infection in northeast Iran.
Author Sadeghian, Mohammad Hadi
Tehranaian, Farahnaz
Keramati, Mohammad Reza
Shakibyee, Hossein
Ayatollahi, Hossein
Feizabadi, Atefeh Shirinzadeh
Author_xml – sequence: 1
  givenname: Mohammad Hadi
  surname: Sadeghian
  fullname: Sadeghian, Mohammad Hadi
  organization: Cancer Molecular Pathology Research Center, Ghaem Hospital, Department of Hematology and Blood Bank, Faculty of Medicine, Mashhad University of Medical Sciences (MUMS), Iran
– sequence: 2
  givenname: Mohammad Reza
  surname: Keramati
  fullname: Keramati, Mohammad Reza
  email: keramatimr@Mums.ac.ir
  organization: Neonatal Research Center, Imam Reza Hospital, Faculty of Medicine, MUMS, Iran
– sequence: 3
  givenname: Hossein
  surname: Ayatollahi
  fullname: Ayatollahi, Hossein
  organization: Department of Hematology and Blood Bank, Faculty of Medicine, MUMS, Iran
– sequence: 4
  givenname: Atefeh Shirinzadeh
  surname: Feizabadi
  fullname: Feizabadi, Atefeh Shirinzadeh
  organization: Cancer Molecular Pathology Research Center, Ghaem Hospital, Faculty of Medicine, MUMS, Iran
– sequence: 5
  givenname: Farahnaz
  surname: Tehranaian
  fullname: Tehranaian, Farahnaz
  organization: Blood Transfusion Center of Khorasan Razavi, Iran
– sequence: 6
  givenname: Hossein
  surname: Shakibyee
  fullname: Shakibyee, Hossein
  organization: Blood Transfusion Center of Khorasan Razavi, Iran
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22858444$$D View this record in MEDLINE/PubMed
BookMark eNqNUs1u3CAYRFWq5qd5hFYce7EDGIytqo2iqElWWqmHprkijD9n2XrBBbvpvn1xdnOJVCWnD8HMADNzjA6cd4DQB0pySmh5ts7HoF00NmeEspyUeRpv0BGtZJXRsioO0prLIiOCsEN0HOOaECppXb5Dh4xVouKcH6FmEfG4ggBYuy0O0OvRehdXdsANjA8ADsPfIUCM8zb2Hd5Y5wNueu9bfB_8NCTmaO8hnT7YcYVvbpd32QJb14GZtc7fo7ed7iOc7ucJ-nn17fbyJlt-v15cXiwzI4gcM2aoEFA0mmtKad1RojkxhHdVLQkX0LbQAZQm_d6UtAYjqkqCIS00hEvJihP0aac7BP97gjiqjY0G-l478FNUlNQFl7ym5SughWScM14l6Mc9dGo20Koh2I0OW_VkYQJ83gFM8DEG6JSx46OLKSDbJy01B6bWah-YmgNTpFRpJLZ4xn664CXe-Y4HydE_FoJKCHAGWhuS76r19kWFr88UTG-dNbr_BVuIaz8Fl-JSVMXEUT_mMs1doiz1SJQiCXz5v8ArHvAPR_PcTA
CitedBy_id crossref_primary_10_1002_jcp_28087
crossref_primary_10_1080_00032719_2017_1287714
crossref_primary_10_1007_s12288_015_0620_4
Cites_doi 10.1128/JVI.01522-06
10.1157/13079179
10.1016/j.chom.2008.06.002
10.3109/10428191003611436
10.1016/j.chom.2009.04.010
10.1007/s11899-007-0035-x
10.1182/blood-2004-11-4267
10.1182/blood-2009-04-215186
10.1111/j.1349-7006.2011.01907.x
10.1089/aid.2006.0140
10.4103/0973-6247.53884
10.1128/IAI.72.6.3429-3435.2004
10.1038/sj.onc.1208968
10.1186/1742-4690-2-27
10.1128/JVI.00389-06
10.1016/j.carres.2007.12.012
10.1182/blood-2010-01-261859
10.3748/wjg.14.4265
10.1080/00313020903041010
10.11150/kansenshogakuzasshi1970.79.664
10.1017/S0950268809991117
10.1186/1742-4690-4-31
10.1089/aid.2008.0002
10.1097/MOH.0b013e32833ece31
10.1016/S0753-3322(99)80021-3
ContentType Journal Article
Copyright 2012 Elsevier Ltd
Elsevier Ltd
Copyright © 2012 Elsevier Ltd. All rights reserved.
Copyright_xml – notice: 2012 Elsevier Ltd
– notice: Elsevier Ltd
– notice: Copyright © 2012 Elsevier Ltd. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7U9
H94
DOI 10.1016/j.transci.2012.06.012
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Virology and AIDS Abstracts
DatabaseTitleList MEDLINE - Academic
MEDLINE

AIDS and Cancer Research Abstracts


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1878-1683
EndPage 154
ExternalDocumentID 22858444
10_1016_j_transci_2012_06_012
S1473050212001565
1_s2_0_S1473050212001565
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
-RU
.1-
.FO
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
29Q
4.4
457
4G.
53G
5VS
7-5
71M
8P~
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFRF
ABJNI
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
M41
MO0
N9A
O-L
O9-
OAUVE
OC~
OO-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SDF
SDG
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
UHS
UNMZH
Z5R
~G-
AACTN
AFKWA
AJOXV
AMFUW
RIG
AAIAV
ABLVK
ABYKQ
AJBFU
EFLBG
LCYCR
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ACLOT
~HD
7U9
H94
ID FETCH-LOGICAL-c507t-2c155e3ba4a1119f10a40c04f897045eddefee6c101c619ec5887ec0deb047723
IEDL.DBID .~1
ISSN 1473-0502
IngestDate Sun Sep 28 08:29:42 EDT 2025
Sat Sep 27 19:52:17 EDT 2025
Mon Jul 21 05:55:53 EDT 2025
Tue Jul 01 02:22:47 EDT 2025
Thu Apr 24 23:09:30 EDT 2025
Fri Feb 23 02:27:57 EST 2024
Sun Feb 23 10:18:44 EST 2025
Tue Aug 26 18:00:25 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Virus
HTLV-I
Blood group
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
Copyright © 2012 Elsevier Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c507t-2c155e3ba4a1119f10a40c04f897045eddefee6c101c619ec5887ec0deb047723
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
PMID 22858444
PQID 1037244248
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_1093474916
proquest_miscellaneous_1037244248
pubmed_primary_22858444
crossref_citationtrail_10_1016_j_transci_2012_06_012
crossref_primary_10_1016_j_transci_2012_06_012
elsevier_sciencedirect_doi_10_1016_j_transci_2012_06_012
elsevier_clinicalkeyesjournals_1_s2_0_S1473050212001565
elsevier_clinicalkey_doi_10_1016_j_transci_2012_06_012
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-10-01
PublicationDateYYYYMMDD 2012-10-01
PublicationDate_xml – month: 10
  year: 2012
  text: 2012-10-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Transfusion and apheresis science
PublicationTitleAlternate Transfus Apher Sci
PublicationYear 2012
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Jones, Fugo, Petrow-Sadowski, Huang, Bertolette, Lisinski (b0110) 2006; 80
Lachgar, Jaureguiberry, Le Buenac, Bizzini, Zagury, Rappaport (b0130) 1998; 52
Yamaoka (b0065) 2008; 14
Proietti, Carneiro-Proietti, Catalan-Soares, Murphy (b0010) 2005; 24
Ukaejiofo, Nubila (b0140) 2006; 25
Sadeghian, Keramati, Badiei (b0090) 2009; 3
Anstee (b0045) 2010; 115
Moran (b0070) 2008; 343
Behal, Jain, Behal, Dhole (b0055) 2010; 138
Miyoshi, Yoshizumi, Sato, Okui, Ogawa, Honma (b0080) 2005; 79
Neil, McKnight, Gustafsson, Weiss (b0120) 2005; 105
He, Neil, Kulkarni, Wright, Agan, Marconi (b0085) 2008; 4
Beadling (b0035) 2007
González-Ordóñez (b0075) 2005; 125
Caskey, Morgan, Porto, Giozza, Muniz, Orge (b0030) 2007 Mar; 23
Winkler, An, Johnson, Nelson, Kirk (b0125) 2009; 5
Kulkarni, Marconi, He, Landrum, Okulicz, Delmar (b0135) 2009; 114
Nakao, Matsuo, Hosono, Ogata, Ito, Watanabe (b0050) 2011; 102
Kinet, Swainson, Lavanya, Mongellaz, Montel-Hagen, Craveiro (b0105) 2007; 15
Branch (b0095) 2010; 17
Takenouchi, Jones, Lisinski, Fugo, Yao, Cushman (b0115) 2007; 81
Tarhini, Kchour, Zanjani, Rafatpanah, Otrock, Bazarbachi (b0025) 2009; 41
Matsuoka (b0100) 2005; 26
Ayatollahi, Rafatpanah, Khayyami, Sayyadpour, Ravarian, Sadeghian (b0020) 2008; 24
Mahieux, Gessain (b0005) 2007; 2
Hennig, Mernaugh, Edl, Cao, Cover (b0060) 2004; 72
Keramati, Sadeghian, Ayatollahi (b0015) 2010 Apr; 51
Calhoun, Petz (b0040) 2010
Proietti (10.1016/j.transci.2012.06.012_b0010) 2005; 24
Branch (10.1016/j.transci.2012.06.012_b0095) 2010; 17
Jones (10.1016/j.transci.2012.06.012_b0110) 2006; 80
Behal (10.1016/j.transci.2012.06.012_b0055) 2010; 138
Mahieux (10.1016/j.transci.2012.06.012_b0005) 2007; 2
Ukaejiofo (10.1016/j.transci.2012.06.012_b0140) 2006; 25
Caskey (10.1016/j.transci.2012.06.012_b0030) 2007; 23
Beadling (10.1016/j.transci.2012.06.012_b0035) 2007
Moran (10.1016/j.transci.2012.06.012_b0070) 2008; 343
Hennig (10.1016/j.transci.2012.06.012_b0060) 2004; 72
Miyoshi (10.1016/j.transci.2012.06.012_b0080) 2005; 79
Neil (10.1016/j.transci.2012.06.012_b0120) 2005; 105
Kinet (10.1016/j.transci.2012.06.012_b0105) 2007; 15
Calhoun (10.1016/j.transci.2012.06.012_b0040) 2010
Kulkarni (10.1016/j.transci.2012.06.012_b0135) 2009; 114
Lachgar (10.1016/j.transci.2012.06.012_b0130) 1998; 52
Tarhini (10.1016/j.transci.2012.06.012_b0025) 2009; 41
Yamaoka (10.1016/j.transci.2012.06.012_b0065) 2008; 14
Ayatollahi (10.1016/j.transci.2012.06.012_b0020) 2008; 24
Keramati (10.1016/j.transci.2012.06.012_b0015) 2010; 51
Nakao (10.1016/j.transci.2012.06.012_b0050) 2011; 102
Sadeghian (10.1016/j.transci.2012.06.012_b0090) 2009; 3
Winkler (10.1016/j.transci.2012.06.012_b0125) 2009; 5
Takenouchi (10.1016/j.transci.2012.06.012_b0115) 2007; 81
González-Ordóñez (10.1016/j.transci.2012.06.012_b0075) 2005; 125
He (10.1016/j.transci.2012.06.012_b0085) 2008; 4
Anstee (10.1016/j.transci.2012.06.012_b0045) 2010; 115
Matsuoka (10.1016/j.transci.2012.06.012_b0100) 2005; 26
References_xml – volume: 23
  start-page: 365
  year: 2007 Mar
  end-page: 371
  ident: b0030
  article-title: Clinical manifestations associated with HTLV type I infection: a cross-sectional study
  publication-title: AIDS Res Hum Retroviruses
– volume: 26
  start-page: 27
  year: 2005
  ident: b0100
  article-title: Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)
  publication-title: Retrovirology
– volume: 51
  start-page: 727
  year: 2010 Apr
  end-page: 729
  ident: b0015
  article-title: Clinical and laboratory features in adult T-cell leukemia/lymphoma in Khorasan, Iran
  publication-title: Leuk Lymphoma
– volume: 3
  start-page: 95
  year: 2009
  end-page: 98
  ident: b0090
  article-title: Alloimmunization among transfusion-dependent thalassemia patients
  publication-title: Asian J Transfus Sci
– volume: 343
  start-page: 1952
  year: 2008
  end-page: 1965
  ident: b0070
  article-title: Relevance of fucosylation and Lewis antigen expression in the bacterial gastroduodenal pathogen
  publication-title: Carbohydr Res
– volume: 125
  start-page: 382
  year: 2005
  end-page: 388
  ident: b0075
  article-title: Blood groups and disease
  publication-title: Med Clin (Barc)
– volume: 15
  start-page: 31
  year: 2007
  ident: b0105
  article-title: Isolated receptor binding domains of HTLV-1 and HTLV-2 envelopes bind Glut-1 on activated CD4+ and CD8+ T cells
  publication-title: Retrovirology
– volume: 138
  start-page: 1096
  year: 2010
  end-page: 1099
  ident: b0055
  article-title: Variation in the host ABO blood group may be associated with susceptibility to hepatitis C virus infection
  publication-title: Epidemiol Infect
– volume: 79
  start-page: 664
  year: 2005
  end-page: 671
  ident: b0080
  article-title: Relationship between ABO histo-blood group type and an outbreak of norovirus gastroenteritis among primary and junior high school students: results of questionnaire-based study
  publication-title: Kansenshogaku Zasshi
– volume: 81
  start-page: 1506
  year: 2007
  end-page: 1510
  ident: b0115
  article-title: GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1
  publication-title: J Virol
– start-page: 621
  year: 2007
  end-page: 638
  ident: b0035
  article-title: Immunohematology
  publication-title: Henry’s clinical diagnosis and management by laboratory methods
– volume: 24
  start-page: 6058
  year: 2005
  end-page: 6068
  ident: b0010
  article-title: Global epidemiology of HTLV-I infection and associated diseases
  publication-title: Oncogene
– volume: 41
  start-page: 498
  year: 2009
  end-page: 499
  ident: b0025
  article-title: Declining tendency of human T-cell leukaemia virus type I carrier rates among blood donors in Mashhad, Iran
  publication-title: Pathology
– volume: 5
  start-page: 411
  year: 2009
  end-page: 413
  ident: b0125
  article-title: Expression of Duffy antigen receptor for chemokines (DARC) has no effect on HIV-1 acquisition or progression to AIDS in African Americans
  publication-title: Cell Host Microbe
– volume: 114
  start-page: 2783
  year: 2009
  end-page: 2792
  ident: b0135
  article-title: The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry
  publication-title: Blood
– volume: 14
  start-page: 4265
  year: 2008
  end-page: 4272
  ident: b0065
  article-title: Roles of
  publication-title: World J Gastroenterol
– volume: 72
  start-page: 3429
  year: 2004
  end-page: 3435
  ident: b0060
  article-title: Heterogeneity among
  publication-title: Infect Immun
– volume: 115
  start-page: 4635
  year: 2010
  end-page: 4643
  ident: b0045
  article-title: The relationship between blood groups and disease
  publication-title: Blood
– volume: 52
  start-page: 436
  year: 1998
  end-page: 439
  ident: b0130
  article-title: Binding of HIV-1 to RBCs involves the Duffy antigen receptors for chemokines (DARC)
  publication-title: Biomed Pharmacother
– volume: 17
  start-page: 558
  year: 2010
  end-page: 564
  ident: b0095
  article-title: Blood groups and susceptibility to virus infection: new developments
  publication-title: Curr Opin Hematol
– volume: 25
  start-page: 61
  year: 2006
  end-page: 64
  ident: b0140
  article-title: Association between ABO, Rhesus blood group systems and haemoglobin genotype among confirmed HIV/AIDS-TB co-infected patients in Enugu Urban, Nigeria
  publication-title: West Afr J Med
– volume: 2
  start-page: 257
  year: 2007
  end-page: 264
  ident: b0005
  article-title: Adult T-cell leukemia/lymphoma and HTLV-I
  publication-title: Curr Hematol Malig Rep
– start-page: 1843
  year: 2010
  end-page: 1859
  ident: b0040
  article-title: Erythrocyte antigens and antibodies
  publication-title: Williams hematology
– volume: 105
  start-page: 4693
  year: 2005
  end-page: 4699
  ident: b0120
  article-title: HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation
  publication-title: Blood
– volume: 102
  start-page: 1076
  year: 2011
  end-page: 1080
  ident: b0050
  article-title: ABO blood group alleles and the risk of pancreatic cancer in Japanese population
  publication-title: Cancer Sci
– volume: 24
  start-page: 1155
  year: 2008
  end-page: 1158
  ident: b0020
  article-title: Association between ABO and Rhesus blood group systems among confirmed human T lymphotropic virus type 1-infected patients in Northeast Iran
  publication-title: AIDS Res Hum Retroviruses
– volume: 4
  start-page: 52
  year: 2008
  end-page: 62
  ident: b0085
  article-title: Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility
  publication-title: Cell Host Microbe
– volume: 80
  start-page: 8291
  year: 2006
  end-page: 8302
  ident: b0110
  article-title: Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells
  publication-title: J Virol
– volume: 81
  start-page: 1506
  year: 2007
  ident: 10.1016/j.transci.2012.06.012_b0115
  article-title: GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1
  publication-title: J Virol
  doi: 10.1128/JVI.01522-06
– volume: 125
  start-page: 382
  issue: 10
  year: 2005
  ident: 10.1016/j.transci.2012.06.012_b0075
  article-title: Blood groups and disease
  publication-title: Med Clin (Barc)
  doi: 10.1157/13079179
– volume: 25
  start-page: 61
  issue: 1
  year: 2006
  ident: 10.1016/j.transci.2012.06.012_b0140
  article-title: Association between ABO, Rhesus blood group systems and haemoglobin genotype among confirmed HIV/AIDS-TB co-infected patients in Enugu Urban, Nigeria
  publication-title: West Afr J Med
– volume: 4
  start-page: 52
  issue: 1
  year: 2008
  ident: 10.1016/j.transci.2012.06.012_b0085
  article-title: Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2008.06.002
– volume: 51
  start-page: 727
  issue: 4
  year: 2010
  ident: 10.1016/j.transci.2012.06.012_b0015
  article-title: Clinical and laboratory features in adult T-cell leukemia/lymphoma in Khorasan, Iran
  publication-title: Leuk Lymphoma
  doi: 10.3109/10428191003611436
– volume: 5
  start-page: 411
  issue: 5
  year: 2009
  ident: 10.1016/j.transci.2012.06.012_b0125
  article-title: Expression of Duffy antigen receptor for chemokines (DARC) has no effect on HIV-1 acquisition or progression to AIDS in African Americans
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2009.04.010
– volume: 2
  start-page: 257
  year: 2007
  ident: 10.1016/j.transci.2012.06.012_b0005
  article-title: Adult T-cell leukemia/lymphoma and HTLV-I
  publication-title: Curr Hematol Malig Rep
  doi: 10.1007/s11899-007-0035-x
– volume: 105
  start-page: 4693
  issue: 12
  year: 2005
  ident: 10.1016/j.transci.2012.06.012_b0120
  article-title: HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation
  publication-title: Blood
  doi: 10.1182/blood-2004-11-4267
– volume: 114
  start-page: 2783
  issue: 13
  year: 2009
  ident: 10.1016/j.transci.2012.06.012_b0135
  article-title: The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry
  publication-title: Blood
  doi: 10.1182/blood-2009-04-215186
– start-page: 621
  year: 2007
  ident: 10.1016/j.transci.2012.06.012_b0035
  article-title: Immunohematology
– start-page: 1843
  year: 2010
  ident: 10.1016/j.transci.2012.06.012_b0040
  article-title: Erythrocyte antigens and antibodies
– volume: 102
  start-page: 1076
  issue: 5
  year: 2011
  ident: 10.1016/j.transci.2012.06.012_b0050
  article-title: ABO blood group alleles and the risk of pancreatic cancer in Japanese population
  publication-title: Cancer Sci
  doi: 10.1111/j.1349-7006.2011.01907.x
– volume: 23
  start-page: 365
  issue: 3
  year: 2007
  ident: 10.1016/j.transci.2012.06.012_b0030
  article-title: Clinical manifestations associated with HTLV type I infection: a cross-sectional study
  publication-title: AIDS Res Hum Retroviruses
  doi: 10.1089/aid.2006.0140
– volume: 3
  start-page: 95
  year: 2009
  ident: 10.1016/j.transci.2012.06.012_b0090
  article-title: Alloimmunization among transfusion-dependent thalassemia patients
  publication-title: Asian J Transfus Sci
  doi: 10.4103/0973-6247.53884
– volume: 72
  start-page: 3429
  issue: 6
  year: 2004
  ident: 10.1016/j.transci.2012.06.012_b0060
  article-title: Heterogeneity among Helicobacter pylori strains in expression of the outer membrane protein BabA
  publication-title: Infect Immun
  doi: 10.1128/IAI.72.6.3429-3435.2004
– volume: 24
  start-page: 6058
  year: 2005
  ident: 10.1016/j.transci.2012.06.012_b0010
  article-title: Global epidemiology of HTLV-I infection and associated diseases
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1208968
– volume: 26
  start-page: 27
  issue: 2
  year: 2005
  ident: 10.1016/j.transci.2012.06.012_b0100
  article-title: Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-2-27
– volume: 80
  start-page: 8291
  issue: 17
  year: 2006
  ident: 10.1016/j.transci.2012.06.012_b0110
  article-title: Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells
  publication-title: J Virol
  doi: 10.1128/JVI.00389-06
– volume: 343
  start-page: 1952
  issue: 12
  year: 2008
  ident: 10.1016/j.transci.2012.06.012_b0070
  article-title: Relevance of fucosylation and Lewis antigen expression in the bacterial gastroduodenal pathogen Helicobacter pylori
  publication-title: Carbohydr Res
  doi: 10.1016/j.carres.2007.12.012
– volume: 115
  start-page: 4635
  issue: 23
  year: 2010
  ident: 10.1016/j.transci.2012.06.012_b0045
  article-title: The relationship between blood groups and disease
  publication-title: Blood
  doi: 10.1182/blood-2010-01-261859
– volume: 14
  start-page: 4265
  issue: 27
  year: 2008
  ident: 10.1016/j.transci.2012.06.012_b0065
  article-title: Roles of Helicobacter pylori BabA in gastroduodenal pathogenesis
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.14.4265
– volume: 41
  start-page: 498
  issue: 5
  year: 2009
  ident: 10.1016/j.transci.2012.06.012_b0025
  article-title: Declining tendency of human T-cell leukaemia virus type I carrier rates among blood donors in Mashhad, Iran
  publication-title: Pathology
  doi: 10.1080/00313020903041010
– volume: 79
  start-page: 664
  issue: 9
  year: 2005
  ident: 10.1016/j.transci.2012.06.012_b0080
  article-title: Relationship between ABO histo-blood group type and an outbreak of norovirus gastroenteritis among primary and junior high school students: results of questionnaire-based study
  publication-title: Kansenshogaku Zasshi
  doi: 10.11150/kansenshogakuzasshi1970.79.664
– volume: 138
  start-page: 1096
  issue: 8
  year: 2010
  ident: 10.1016/j.transci.2012.06.012_b0055
  article-title: Variation in the host ABO blood group may be associated with susceptibility to hepatitis C virus infection
  publication-title: Epidemiol Infect
  doi: 10.1017/S0950268809991117
– volume: 15
  start-page: 31
  issue: 4
  year: 2007
  ident: 10.1016/j.transci.2012.06.012_b0105
  article-title: Isolated receptor binding domains of HTLV-1 and HTLV-2 envelopes bind Glut-1 on activated CD4+ and CD8+ T cells
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-4-31
– volume: 24
  start-page: 1155
  year: 2008
  ident: 10.1016/j.transci.2012.06.012_b0020
  article-title: Association between ABO and Rhesus blood group systems among confirmed human T lymphotropic virus type 1-infected patients in Northeast Iran
  publication-title: AIDS Res Hum Retroviruses
  doi: 10.1089/aid.2008.0002
– volume: 17
  start-page: 558
  issue: 6
  year: 2010
  ident: 10.1016/j.transci.2012.06.012_b0095
  article-title: Blood groups and susceptibility to virus infection: new developments
  publication-title: Curr Opin Hematol
  doi: 10.1097/MOH.0b013e32833ece31
– volume: 52
  start-page: 436
  issue: 10
  year: 1998
  ident: 10.1016/j.transci.2012.06.012_b0130
  article-title: Binding of HIV-1 to RBCs involves the Duffy antigen receptors for chemokines (DARC)
  publication-title: Biomed Pharmacother
  doi: 10.1016/S0753-3322(99)80021-3
SSID ssj0017196
Score 1.9791765
Snippet The frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2–3% in the general population and 0.7% in blood donors in northeast Iran. It is very important that...
AbstractBackgroundThe frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2–3% in the general population and 0.7% in blood donors in northeast Iran. It is...
The frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2-3% in the general population and 0.7% in blood donors in northeast Iran. It is very important that...
Background: The frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2-3% in the general population and 0.7% in blood donors in northeast Iran. It is very...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 151
SubjectTerms Adolescent
Adult
Antibodies
Blood donors
Blood group
Blood Group Antigens - biosynthesis
Blood Group Antigens - immunology
Blood groups
Case-Control Studies
Computer programs
Hematology, Oncology, and Palliative Medicine
HTLV-I
HTLV-I Infections - blood
HTLV-I Infections - immunology
Human T-lymphotropic virus 1
Humans
Infection
Middle Aged
Prospective Studies
software
Virus
Young Adult
Title Is there any relationship between expressions of minor blood group antigens with HTLV-I infection?
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1473050212001565
https://www.clinicalkey.es/playcontent/1-s2.0-S1473050212001565
https://dx.doi.org/10.1016/j.transci.2012.06.012
https://www.ncbi.nlm.nih.gov/pubmed/22858444
https://www.proquest.com/docview/1037244248
https://www.proquest.com/docview/1093474916
Volume 47
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier)
  customDbUrl:
  eissn: 1878-1683
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017196
  issn: 1473-0502
  databaseCode: GBLVA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier ScienceDirect
  customDbUrl:
  eissn: 1878-1683
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017196
  issn: 1473-0502
  databaseCode: .~1
  dateStart: 20010201
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Complete Freedom Collection [SCCMFC]
  customDbUrl:
  eissn: 1878-1683
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017196
  issn: 1473-0502
  databaseCode: ACRLP
  dateStart: 20010201
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals [SCFCJ]
  customDbUrl:
  eissn: 1878-1683
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017196
  issn: 1473-0502
  databaseCode: AIKHN
  dateStart: 20010201
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1878-1683
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017196
  issn: 1473-0502
  databaseCode: AKRWK
  dateStart: 20010201
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEB9KC-KLWD9P27KCr-llN5Pby5OUo-VO2yLaSt-WZLNLI5o7Lin45N_uTLI5Ea0Vn_LBDrtMZmZ_m_3NLMDrMtWYp9ZFk0wmEbrEk0tZGZWFllz7JNGO853PzifzS3x7lV5twWzIhWFaZYj9fUzvonV4Mw7aHK-qavxRIllnyiXKu3xgTjTn6l9k04ffNzQPqWXWZxhp5qkxm2f_J8er5fnAVszwUl0ZT6lum59uw5_dPHTyEB4EACmO-jHuwparH8G9s7BF_hiKRSMY1DlBbi7WA9ftulqJwMkS7ltgv9aNWHrxtaqXa9Ex2EWX5EGSLRfpbAT_pRXzi9NP0UIMtK36zRO4PDm-mM2jcJBCZAnutZGyhBpcUuSYU2jLvIxzjG2MfpppgnSOQpx3bmJJK5YWVM6mFHqcjUtXxEjwO3kK2_Wyds9BaO9jT2tOLJVHi6qIfZHSbVomkhY3OAIc1GdsqDLOh118MQOd7LMJWjesdcO0OqlGcLgRW_VlNu4SmAzfxgw5pBT1DE0EdwnqPwm6JvhuY6RpqLH5zb5GMN1I_mKi_9Lpq8F8DLkv78nktVveUGdxoglhKZz-rU2WoEYC8iN41tveRklKTQlCIr74_8G9hPv81DMU92C7Xd-4fUJabXHQudIB7BzNPpy-5-vi3fz8BwHUKTA
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-NTgJeEN8UGBiJ19DYOdfNE5omppS1faFDe7MSx9aCIK2aTOLP55w4RQjGEG9R4pOjy338HP_uDPC2lApzaWw0TXkSoU0cuZThUVko7nufJMr6euflapqd48cLeXEAJ0MtjKdVhtjfx_QuWoc7k6DNybaqJp84knVK36K8qweWt-AQJcXkERwez8-y1X4zQfG0LzJSnqrmCT1HP2lerU8JpvIkL9F18uTiuhR1HQTtUtHpfbgXMCQ77l_zARzY-iHcXoZd8kdQzBvmcZ1l5OlsN9DdLqstC7QsZr8HAmzdsI1j36p6s2MdiZ11dR4k2fo-nQ3zP2pZtl58juZsYG7V7x_D-emH9UkWhbMUIkOIr42EIeBgkyLHnKJb6nicY2xidLNUEaqzFOWctVNDWjG0prJGUvSxJi5tESMh8OQJjOpNbZ8BU87FjpadWAqHBkURu0LSpSwTTusbHAMO6tMmNBr351181QOj7IsOWtde69oz67gYw7u92LbvtHGTwHT4NnooI6XApykX3CSo_iRom-C-jea6ocH6NxMbw2wv-YuV_sukbwbz0eTBflsmr-3miiaLE0UgS-Dsb2PSBBUSlh_D09729koSYkYoEvH5_7_ca7iTrZcLvZivzl7AXf-kJyy-hFG7u7JHBLza4lVwrB-1aCpG
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Is+there+any+relationship+between+expressions+of+minor+blood+group+antigens+with+HTLV-I+infection%3F&rft.jtitle=Transfusion+and+apheresis+science&rft.au=Sadeghian%2C+Mohammad+Hadi&rft.au=Keramati%2C+Mohammad+Reza&rft.au=Ayatollahi%2C+Hossein&rft.au=Feizabadi%2C+Atefeh+Shirinzadeh&rft.date=2012-10-01&rft.issn=1473-0502&rft.volume=47&rft.issue=2&rft.spage=151&rft.epage=154&rft_id=info:doi/10.1016%2Fj.transci.2012.06.012&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_transci_2012_06_012
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F14730502%2FS1473050212X00065%2Fcov150h.gif